Page last updated: 2024-08-22

mopidamol and Experimental Mammary Neoplasms

mopidamol has been researched along with Experimental Mammary Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19903 (75.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lichtner, RB; Schirner, M; Schneider, MR1
Butcher, RW; Goka, TJ; Lichtner, RB; Nicolson, GL1
Gallick, GE; Lichtner, RB; Nicolson, GL1
Lichtner, RB; Nicolson, GL1

Other Studies

4 other study(ies) available for mopidamol and Experimental Mammary Neoplasms

ArticleYear
The stable prostacyclin analogue Cicaprost inhibits metastasis to lungs and lymph nodes in the 13762NF MTLn3 rat mammary carcinoma.
    Clinical & experimental metastasis, 1994, Volume: 12, Issue:1

    Topics: Animals; Antineoplastic Agents; Dose-Response Relationship, Drug; Epoprostenol; Female; Lung Neoplasms; Lymphatic Metastasis; Mammary Neoplasms, Experimental; Mopidamol; Rats; Rats, Inbred F344

1994
Direct effects of the pyrimido-pyrimidine derivative RA 233 (Rapenton) on rat 13762NF mammary tumor cell clones in vitro.
    Cancer research, 1987, Apr-01, Volume: 47, Issue:7

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Antimetabolites, Antineoplastic; Cell Division; Cell Line; Cell Survival; Clone Cells; Cyclic AMP; Female; Kinetics; Mammary Neoplasms, Experimental; Mopidamol; Pyrimidines; Rats

1987
Pyrimido-pyrimidine modulation of EGF growth-promoting activity and p21ras expression in rat mammary adenocarcinoma cells.
    Journal of cellular physiology, 1988, Volume: 137, Issue:2

    Topics: Adenocarcinoma; Animals; Cell Division; Epidermal Growth Factor; Mammary Neoplasms, Experimental; Mopidamol; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); Pyrimidines; Rats

1988
The pyrimido-pyrimidine derivatives RA 233 and RX-RA 85 affect growth and cytoskeletal organization of rat mammary adenocarcinoma cells.
    European journal of cancer & clinical oncology, 1987, Volume: 23, Issue:9

    Topics: Actin Cytoskeleton; Adenocarcinoma; Animals; Cell Line; Cell Survival; Cytoskeleton; Dose-Response Relationship, Drug; Mammary Neoplasms, Experimental; Microtubules; Mopidamol; Phosphodiesterase Inhibitors; Pyrimidines; Rats; Vacuoles

1987